“Gene tests as potential guides for treatments” 
(July 12) International Herald Tribune reports, “A decade or so ago, when the revolution in genetics was getting under way, the air was heady with promises.”
“Routine ECGs for newborns would identify life-threatening heart condition”
(July 12) EurekAlert! reports, “Italian heart specialists are calling on health care providers throughout Europe to give urgent consideration to introducing ECG screening for all babies at around three to four weeks of age to pick up a life-threatening genetic condition called long QT syndrome.”
“Women with mutations in BRCA1 or BRCA2 genes can reduce cancer risk by having ovaries
removed”
(July 12) News-Medical.Net reports, “Women with mutations in the BRCA1 or BRCA2 genes can significantly reduce their risk of certain types of cancer by having their ovaries removed, according to a study in the July 12 issue of Journal of the American Medical Association.”
“South has 'key role' studying genetic links to disease”
(July 11) SciDev.Net reports, “Researchers in developing nations are at the forefront of global efforts to develop a database of information about how human genetics influences disease.”
“Imaging technology points to small molecules that can fight treatment-resistant tumors”
(July 11) EurekAlert! reports, “Using a newly developed drug screen, researchers at the University of Pennsylvania School of Medicine have discovered small molecule compounds that are able to perform the functions of a gene commonly mutated in many types of cancer.”
“Does My Diet Fit My Genes?”
(July 11) Time reports, “The new science of nutrigenomics has some answers.”
“States Doubled Number of Newborns Tested for Genetic Diseases”
(July 11) Fox News.com reports, “States have nearly doubled the number of newborns being tested for a host of rare but devastating genetic diseases -- yet where you live still determines just how protected your baby will be, the March of Dimes reports.”
“Genetic variation found that predicts response to heart failure medication”
(July 10) EurekAlert! reports, “Researchers at the University of Maryland School of Medicine in Baltimore and the University of Colorado School of Medicine in Denver have identified a common genetic variation that could help determine whether a person with heart failure would benefit from beta-blockers, a class of drugs used to treat chronic heart failure.”
“Ensuring That Genetic Testing From Different Laboratories Yields the Same Results”
(July 10) Innovations Report reports, “For individuals who develop colorectal cancers at a young age or have a family history of such cancers, microsatellite instability testing (MSI) has become an almost standard component of clinical evaluation.”
“Women with damaged ATM gene more likely to develop cancer”
(July 10) Guardian Unlimited reports, “Women who inherit a damaged version of a particular gene are more than twice as likely to develop breast cancer, according to research published today.”
“The inability to recognize faces can be inherited”
(July 9) News-Medical.Net reports, “In the first study to examine whether the inability to recognize faces can be inherited, researchers found that it is in fact a common disorder that runs in families and is one of the most frequent disorders apparently controlled by a defect in a single gene.”
“Cell survival depends on chromosome integrity”
(July 9) News-Medical.Net reports, “UCLA researchers report that thousands of genes behave differently in the same organs of males and females - something never detected to this degree.”
“College Urges Reexamination of Gene Patenting and Licensing”
(July 6) College of American Pathologists reports, “CAP President Thomas M. Sodeman, MD, FCAP, testified June 27 on behalf of the College before the U.S. House Subcommittee on Criminal Justice, Drug Policy and Human Resources regarding the Government Accountability Office (GAO) report, Clinical Lab Quality, CMS and Survey Organization Oversight Should Be Strengthened.”
“Gene Mutations Don't Add To The Risk Of Blood Clots In Women Taking Tamoxifen”
(July 6) Medical News Today reports, “Two genetic mutations may not increase the risk of blood clots in women taking tamoxifen for breast cancer prevention.”
“Cancer researchers confirm brain tumor genetic subtype informs treatment, predicts outcome”
(July 6) EurekAlert! reports, “Research confirms that determining the genetic composition of brain cancers can better inform doctors and patients for treatment options and prognosis.”
|